Bharat Biotech seeks emergency use authorisation for Covaxin, days after Pfizer and SII

Last week, Prime Minister Narendra Modi had said that a COVID-19 vaccine 'may be ready in a few weeks' at an all-party meeting

Press Trust of India December 08, 2020 07:00:57 IST
Bharat Biotech seeks emergency use authorisation for Covaxin, days after Pfizer and SII

COVAXIN vaccine by Bharath Biotech.

New Delhi: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator Central Drugs Standard Control Organisation (CDSCO), seeking emergency use authorisation for its COVID-19 vaccine Covaxin, official sources said. Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

On 4 December, Prime Minister Narendra Modi at an all-party meeting had expressed hope that a COVID-19 vaccine may be ready in a few weeks.

That same evening, the Indian arm of US pharmaceutical giant Pfizer sought emergency use approval for its vaccine from the central drug regulator, after the firm secured such clearance in the UK and Bahrain.

The Serum Institute sought such nod for the Oxford COVID-19 vaccine, Covishield, on 6 December.

The applications of Bharat Biotech, Serum Institute of India and Pfizer will be reviewed by the subject expert committee (SEC) on COVID-19 at the CDSCO in the coming days.

"However, none of the applications has so far been forwarded to the committee and no date has been fixed as on when the SEC will meet for assessing and evaluating the applications," the official source said.

Updated Date:

also read

China's COVID Conundrum: Why the virus is showing no signs of slowing down
World

China's COVID Conundrum: Why the virus is showing no signs of slowing down

China reported 31,454 fresh coronavirus cases, as per the official data on Thursday. This is the highest daily figure since the virus was detected in Wuhan in 2019. Despite a strict zero-COVID policy, why has the country not been able to stop the surge?

China reports first COVID-19 death in almost six months
World

China reports first COVID-19 death in almost six months

While China has an overall vaccination rate of more than 92 per cent having received at least one dose, that number is considerably lower among the elderly, particularly those over age 80

Beijing goes into semi-lockdown as COVID-19 cases start rising in China
World

Beijing goes into semi-lockdown as COVID-19 cases start rising in China

COVID-19 cases in China on Friday rose to over 25,000, including more than 500 in Beijing, prompting city officials to advise millions of residents to stay home and undergo daily testing